Arizona Liver Health

A Big Milestone: Our First Phase 1 Patient! We’re thrilled to share that we’ve welcomed our very first ACT Phase 1 clinical trial patient at Arizona Clinical Trials, Powered by Arizona Liver Health! This is an exciting step toward finding new treatments and improving care for liver diseases, and we couldn’t be more grateful for the courage of our patients who make this research possible. In this video, you’ll meet our first patient and hear about their journey through the trial process. Their story is a powerful reminder of how clinical trials are helping to shape the future of healthcare. Watch the video?to learn more and see how you, too, can be a part of something that could change lives! Thank you to all who support this important work. Your participation could be the key to breakthroughs in liver disease care. To learn more about our Phase 1 capablities, click the link below https://lnkd.in/gG7S8WH7 #LiverHealth #ClinicalTrials #PatientCare #Phase1Research #ArizonaLiverHealth #JoinTheJourney Naim Alkhouri, MD, FAASLD Anita Kohli Richard Manch Ann Moore Angie Coste Tessa Janovsky Rida Nadeem, MD, MSPH Esteban Rafael Lugo Morales Reichard R. Aileen Tammany Chelsea Ann Mihaylo Hum, PMP Kelly Carey Dylan Moore Novemi Alejandro Mazen Noureddin, MD, MHSc Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter Shelley Miceli Madrigal Pharmaceuticals Fortrea Novo Nordisk Bristol Myers Squibb Syneos Health IQVIA Ipsen 89bio Akero Therapeutics Inventiva Sonic Incytes Medical Corp. Echosens Perspectum Ltd Fatty Liver Alliance Timothy Watkins, MD MSc Michael Cooreman Summit Clinical Research Sophie JEANNIN MEGNIEN

We had a fantastic time at last night’s Provider Dinner in Flagstaff, AZ! A big thank you to all who joined us to celebrate the expansion of Arizona Liver Health to Northern Arizona. It’s an exciting opportunity to bring life-saving liver care, including FREE liver scans, to the community. Special thanks to our incredible partners for their unwavering support: Madrigal Pharmaceuticals Ipsen Gilead Sciences Echosens Novo Nordisk We were proud to have our Arizona Liver Health team members Dylan Moore, Anita Kohli, Ann Moore, and Richard Manch leading the way in advancing liver health and care across the state. Together, we are making strides toward better liver health for all. Anita Kohli Naim Alkhouri, MD, FAASLD Ann Moore Richard Manch Angie Coste Tessa Janovsky Rida Nadeem, MD, MSPH Dylan Moore Brennin Palfrey Colleen Hopkins Esteban Rafael Lugo Morales Reichard R. Michelle Jones Nick Engelke John Raslavsky Desirae Trotter Anne Payne Jesus Topete Kelly Black

As part of Arizona Liver Health’s initiative for Liver Health Awareness Month, we are dedicated to promoting the critical importance of early detection for prevention of liver disease. The liver is a resilient organ, often showing little to no symptoms until disease has progressed, making it vital to raise awareness about the steps people can take to safeguard their liver health early on. By emphasizing proactive measures, we aim to educate the public on the significance of early screening and prevention to reduce the incidence of serious liver conditions such as MASLD, hepatitis, and liver cancer. This month, we are highlighting key reminders that can help detect liver issues in their earliest stages, when treatment is most effective and long-term health outcomes are significantly improved. Whether through routine check-ups, lifestyle changes, or being vigilant about subtle symptoms, early action can make all the difference. Here are some early detection strategies we encourage everyone to incorporate into their healthcare routine: 1.Get Regular Liver Screenings:?Early liver disease often shows no symptoms. Regular screenings, especially for those at high risk (like individuals with excess weight, diabetes, or a history of alcohol use), can catch liver issues before they become severe. 2.Know Your Liver Health Numbers:?Encourage followers to get their liver enzyme levels (ALT, AST) checked through a simple blood test to monitor liver function. 3. Watch for Subtle Symptoms:?Remind people to pay attention to early symptoms like fatigue, nausea, or unexplained weight loss, which can signal liver problems. 4.Manage Risk Factors:?Highlight lifestyle factors such as maintaining a healthy weight, limiting alcohol intake, and avoiding the misuse of medications to lower the risk of liver disease. 5.Get Vaccinated:?Vaccination against hepatitis A and B can prevent liver infections, which are major causes of liver disease. 6.Regular Check-ups for Those at Risk:?People with conditions like hepatitis, diabetes, or non-alcoholic fatty liver disease (NAFLD) should be proactive in managing their liver health with routine monitoring. 7.Early Detection Saves Lives:?Emphasize that conditions like MASLD (formerly NAFLD) or liver cancer can be treated effectively if detected early. Anita Kohli Naim Alkhouri, MD, FAASLD Chelsea Ann Mihaylo Hum, PMP Angie Coste Richard Manch Ann Moore Dylan Moore Michelle Jones Nick Engelke John Raslavsky Desirae Trotter Anne Payne Jesus Topete Esteban Rafael Lugo Morales American Association for the Study of Liver Diseases (AASLD) Global Liver Institute American Liver Foundation Fatty Liver Alliance EASL | The Home of Hepatology

We're proud to announce the promotion of Kelly Black to Marketing Manager at Arizona Liver Health | Arizona Clinical Trials! ? Kelly joined the AZ Liver Health team in early 2023, starting as a Marketing Coordinator and working her way up to Associate Marketing Manager by the summer of 2023. Her hard work and innovative ideas for the Commercial Operations team in the last year reflect her dedication to providing quality services to foster internal and external relationships and boost our organization’s brand recognition within our community and support the organization’s marketing and patient recruitment needs. “I’m excited and honored to step into my new role as Marketing Manager. I’m incredibly grateful to Michelle Jones, my team, and our leadership for their support and encouragement here at ALH, ACT, and VEN,” says Kelly Black, Marketing Manager. Help us congratulate Kelly on this well-deserved promotion and visit www.azliver.com for career opportunities!? Anita Kohli Naim Alkhouri, MD, FAASLD Chaher Sakkal Jennifer Jackson Kristin Fillingham Carrie Tye JM W. Chelsea Ann Mihaylo Hum, PMP Brett Lantz Angie Coste Richard Manch Ann Moore Dylan Moore Michelle Jones Nick Engelke John Raslavsky Desirae Trotter Anne Payne Jesus Topete Esteban Rafael Lugo Morales

We are excited to announce the promotion of Jane O'Neal, SHRM-CP to our new Director of Human Resources at Arizona Liver Health | Arizona Clinical Trials! Jane has been part of the Arizona Liver Health family since April of 2019, starting as a Provider Liaison and working closely with both Dr. Anita Kohli and Dr. Naim Alkhouri, MD, FAASLD to learn about the organization, its operations, and its relationships within the community. In early 2021, Jane helped launch the company’s HR department and over the years, helped scale the company’s operations to its current workforce size while providing critical HR support regarding employee relations, talent recruitment, and benefits. “I am thrilled to take on this new role/challenge and thank Dr. Kohli, Chaher Sakkal, and my HR team for their continued support for my career growth in HR, “ says Jane O’Neil, Director of HR. Help us congratulate Jane on this well-deserved promotion and visit www.azliver.com for career opportunities!? Anita Kohli Naim Alkhouri, MD, FAASLD Chaher Sakkal Jennifer Jackson Kristin Fillingham Carrie Tye JM W. Tasha Brozman, Chelsea Ann Mihaylo Hum, PMP Brett Lantz Angie Coste Richard Manch Ann Moore Dylan Moore Michelle Jones Kelly Black Nick Engelke John Raslavsky Desirae Trotter Anne Payne Jesus Topete Esteban Rafael Lugo Morales

Hot off the press! The Chandler Independent has featured the grand opening of the new ACT Medical and Research Park in South Chandler. This state-of-the-art facility is set to drive innovation in healthcare, offering cutting-edge medical services and research opportunities to the community. Read more about how this new development is enhancing healthcare access and transforming the local landscape in Chandler. Check out the full article here! https://lnkd.in/g-zjBGsp Naim Alkhouri, MD, FAASLD Anita Kohli Richard Manch Ann Moore Angie Coste Tessa Janovsky Rida Nadeem, MD, MSPH Esteban Rafael Lugo Morales Reichard R. Aileen Tammany Chelsea Ann Mihaylo Hum, PMP Kelly Carey Dylan Moore Novemi Alejandro Mazen Noureddin, MD, MHSc Michelle Jones Kelly Black Nick Engelke Anne Payne Desirae Trotter Brett Lantz Brennin Palfrey Colleen Hopkins Madrigal Pharmaceuticals Fortrea Novo Nordisk Bristol Myers Squibb Syneos Health IQVIA Ipsen Medpace 89bio Akero Therapeutics Inventiva Pharma Sonic Incytes Medical Corp. Echosens Perspectum Ltd Fatty Liver Alliance

"At Viral ElimiNation (VEN) Centers, we are on the front lines of Arizona’s fight to eliminate hepatitis C (HCV), reaching underserved and unserved populations where healthcare access is limited. Through our innovative outreach and telehealth-based treatment model, we have brought testing and treatment directly to the streets in high volumes—giving hope and healing to those who need it most. Our findings reveal an alarming trend: over?15%?of unsheltered individuals and people who use drugs (PWUD) are testing reactive for past exposure to HCV. This syndemic of HCV, substance use, and homelessness requires urgent action. Without enhanced support and testing resources, the ripple effect of untreated HCV will continue to devastate these vulnerable populations, further straining our healthcare systems and deepening health inequities. We cannot solve this alone. We need the support of our communities, healthcare partners, and policymakers to: Expand HCV Testing Resources: Increase funding for rapid HCV testing and expand partnerships with harm reduction and homeless services organizations to reach every corner of our state. Enhance Supportive Services: Invest in services essential to health management—stable housing, addiction treatment, mental health care, and case management—critical in addressing the root causes that perpetuate the HCV epidemic. Drive Policy Change: Advocate for expanded public health initiatives that focus on underserved populations, including increased access to harm reduction tools and elimination of the insurance and pharmacy imposed barriers to delivering comprehensive HCV care." - Dylan Moore #VENCenters #HCVcare #ViralElimiNation #SupportiveService Dylan Moore Ann Moore Brennin Palfrey Anita Kohli Richard Manch Colleen Hopkins Kylee Newgass Tessa Janovsky Gavin Ferguson Marianne Rosati Rida Nadeem, MD, MSPH Colleen Hopkins Chelsea Ann Mihaylo Hum, PMP Arizona Liver Health AbbVie Gilead Sciences Jake Winans, MSN, RN, FNP-C Amy Rust Carlos Flores Michelle Jones Kelly Black Nick Engelke

Enhance Your Clinical Skills with @Arizona Liver Health!? Join our ALH | ACT Learning Academy’s Advanced MASLD Learning Preceptorship Program to gain comprehensive insights into the latest advancements in MASLD/MASH. This 1-2 day program offers tailored training sessions, including noninvasive diagnostic techniques and patient-provider interactive workshops. What You’ll Learn:? - Impact of steatotic liver disease: Deepen your understanding of the healthcare burden posed by MASLD, including its prevalence, risk factors, and economic impact.? - Future therapeutic landscapes: Explore new and upcoming treatments for MASLD, including pharmacologic and lifestyle interventions, and their potential to alter the disease course.? - Hands-on experience: Engage in practical sessions with FibroScan? and Hepatoscope?, enhancing your ability to perform and interpret these noninvasive tests accurately. Don’t miss this opportunity to expand your professional expertise and improve patient outcomes. ?? Call us: 303-406-1735? ?? Email: Michelle Jones,?[email protected]? ?? Submit Request:?https://lnkd.in/gBmT6-Zp #LiverDisease #MedicalPreceptorship #HealthcareExcellence #ProfessionalDevelopment Naim Alkhouri, MD, FAASLD?Anita Kohli?Richard Manch?Ann Moore?Tessa Janovsky?Mazen Noureddin, MD, MHSc?Meena Bansal?Boehringer Ingelheim?Novo Nordisk?Madrigal Pharmaceuticals?Nick Engelke?Kelly Black?Anne Payne?Desirae Trotter?Michelle Jones Boston Scientific Boston Pharmaceuticals Echosens Sonic Incytes Medical Corp. Akero Therapeutics Altimmune, Inc.

In celebration of HR Professionals Day, we want to give a big shoutout to our amazing HR team for their dedication and hard work. From recruiting the best talent and supporting employee relations to creating a positive workplace where we all thrive, they play a key role in our company’s success. Let’s take a moment to appreciate and thank our HR team for all they do. Chelsea Ann Mihaylo Hum, PMP Jane O'Neal, SHRM-CP Kristin Fillingham Carrie Tye Jennifer Jackson JM W. Anita Kohli Naim Alkhouri, MD, FAASLD Richard Manch Ann Moore Rida Nadeem, MD, MSPH Tessa Janovsky Yessica Sachdeva Angie Coste Esteban Rafael Lugo Morales Reichard R. Michelle Jones Kelly Black Nick Engelke

Arizona Liver Health is excited to?invite?you to be a sponsor at the Desert Liver Conference 2025, taking place at the beautiful Scott Resort and Spa in Scottsdale, AZ?on March 7-8, 2025. This premier event offers a unique opportunity to?present and network?with leading healthcare professionals dedicated to liver disease care. As a sponsor, you'll have the chance to showcase your cutting-edge technology, pharmaceutical solutions, and services that are essential for the diagnosis, treatment, and management of liver disease. Engage face-to-face with key decision-makers, generate new leads, and introduce your innovations to an audience that values advanced solutions in hepatology. Sponsoring the DLC 2025 will help you expand your market reach, strengthen existing customer relationships, and enhance your company’s visibility in a competitive marketplace. Don’t miss this opportunity to make a lasting impact in the liver disease healthcare community. For the full sponsor prospectus and more details, visit our website,?www.desertliver.com Please contact Heather Lynch Walters at?[email protected]?with elm Planning, or Michelle Jones at?[email protected]?with Arizona Liver Health to discuss sponsorship options. 89bio, AbbVie, AcariaHealth, Aegle, Akero Therapeutics, Altimmune, Inc., AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Boston Pharmaceuticals, Boston Scientific, Celerion, Cook Medical, CVS Pharmacy, CymaBay Therapeutics, DURECT Corporation, Dynavax GmbH, Echosens, Eli Lilly and Company, E-Scopics, Exact Sciences, Fibronostics, Fortea, Galectin Therapeutics, Genentech, GENFIT, Gilead Sciences, Hepion Pharmaceuticals, HistoIndex, Intercept Pharmaceuticals, Inventiva Pharma, Ipsen, Kowa Pharmaceuticals America, Inc., Labcorp, Madrigal Pharmaceuticals, Mallinckrodt Pharmaceuticals, McKesson Merck, Novo Nordisk, Owlstone Medical